84 related articles for article (PubMed ID: 1131817)
1. Identification of phosphorodiamidic acid mustard as a human metabolite of cyclop hosphamide.
Fenselau C; Kan MN; Billets S; Colvin M
Cancer Res; 1975 Jun; 35(6):1453-7. PubMed ID: 1131817
[TBL] [Abstract][Full Text] [Related]
2. Quantification by gas chromatography of N,N'-di-(2-chloroethyl)-phosphorodiamidic acid in the plasma of patients receiving isophosphamide.
Bryant BM; Jarman M; Baker MH; Smith IE; Smyth JF
Cancer Res; 1980 Dec; 40(12):4734-8. PubMed ID: 7438105
[TBL] [Abstract][Full Text] [Related]
3. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
Jardine I; Fenselau C; Appler M; Kan MN; Brundrett RB; Colvin M
Cancer Res; 1978 Feb; 38(2):408-15. PubMed ID: 620410
[TBL] [Abstract][Full Text] [Related]
4. Alkylating properties of phosphoramide mustard.
Colvin M; Brundrett RB; Kan MN; Jardine I; Fenselau C
Cancer Res; 1976 Mar; 36(3):1121-6. PubMed ID: 1253171
[TBL] [Abstract][Full Text] [Related]
5. The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.
Momerency G; Van Cauwenberghe K; Slee PH; Van Oosterom AT; De Bruijn EA
Biol Mass Spectrom; 1994 Mar; 23(3):149-58. PubMed ID: 8148406
[TBL] [Abstract][Full Text] [Related]
6. Approaches to the pharmacokinetics of cyclophosphamide (NSC 26271): Quantitation of metabolites.
Jardine I; Brundrett R; Colvin M; Fenselau C
Cancer Treat Rep; 1976 Apr; 60(4):403-8. PubMed ID: 1277214
[TBL] [Abstract][Full Text] [Related]
7. Review of the metabolism and mode of action of cyclophosphamide.
Fenselau C
J Assoc Off Anal Chem; 1976 Sep; 59(5):1028-36. PubMed ID: 965325
[TBL] [Abstract][Full Text] [Related]
8. Identification of aldophosphamide as a metabolite of cyclophosphamide in vitro and in vivo in humans.
Fenselau C; Kan MN; Rao SS; Myles A; Friedman OM; Colvin M
Cancer Res; 1977 Aug; 37(8 Pt 1):2538-43. PubMed ID: 872080
[TBL] [Abstract][Full Text] [Related]
9. Identification and quantitation of alcophosphamide, a metabolite of cyclophosphamide, in the rat using chemical ionization mass spectrometry.
Hong PS; Chan KK
Biomed Environ Mass Spectrom; 1987 Apr; 14(4):167-72. PubMed ID: 2954602
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of deuterium-labeled analogs of cyclophosphamide and its metabolites.
Griggs LJ; Jarman M
J Med Chem; 1975 Nov; 18(11):1102-6. PubMed ID: 1177255
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.
Brock N
Cancer Treat Rep; 1976 Apr; 60(4):301-8. PubMed ID: 1277205
[TBL] [Abstract][Full Text] [Related]
12. Qualitative and quantitative investigations of cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and related compounds by field-desorption mass spectrometry.
Schulten HR
Cancer Treat Rep; 1976 Apr; 60(4):501-7. PubMed ID: 1277227
[TBL] [Abstract][Full Text] [Related]
13. Monitoring the behaviour of 4-ketocyclophosphamide versus cyclophosphamide during capillary gas chromatography by mass spectrometry.
de Bruijn EA; van Oosterom AT; Leclercq PA; de Haan JW; van de Ven LJ; Tjaden UR
Biomed Environ Mass Spectrom; 1987 Nov; 14(11):643-7. PubMed ID: 2962671
[TBL] [Abstract][Full Text] [Related]
14. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
Hemminki K
Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.
Hong PS; Srigritsanapol A; Chan KK
Drug Metab Dispos; 1991; 19(1):1-7. PubMed ID: 1673381
[TBL] [Abstract][Full Text] [Related]
16. Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometry.
Kasel D; Jetter A; Harlfinger S; Gebhardt W; Fuhr U
Rapid Commun Mass Spectrom; 2004; 18(13):1472-8. PubMed ID: 15216508
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cyclophosphamide (NSC-26271) metabolites and related derivatives by field-desorption and electron-impact mass spectrometry.
Przybylski M; Ringsdorf H; Voelcker G; Draeger U; Peter G; Hohorst HJ
Cancer Treat Rep; 1976 Apr; 60(4):509-16. PubMed ID: 1277228
[TBL] [Abstract][Full Text] [Related]
18. A biologically active metabolite of cyclophosphamide.
Colvin M; Padgett CA; Fenselau C
Cancer Res; 1973 Apr; 33(4):915-8. PubMed ID: 4696485
[No Abstract] [Full Text] [Related]
19. A search for new metabolites of N,N',N''-triethylenethiophosphoramide.
van Maanen MJ; Tijhof IM; Damen JM; Versluis C; van den Bosch JJ; Heck AJ; Rodenhuis S; Beijnen JH
Cancer Res; 1999 Sep; 59(18):4720-4. PubMed ID: 10493531
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric characterization of activated N-(2-chloroethyl)amino oxazaphosphorine derivative.
Przybylski M; Ringsdorf H; Lenssen U; Peter G; Voelcker G; Wagner T; Hohorst HJ
Biomed Mass Spectrom; 1977 Aug; 4(4):209-15. PubMed ID: 912018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
